Reactive oxygen species known as ROS are highly active molecules containing oxygen such as superoxide anions, hydrogen peroxide, and hydroxyl radicals. Although they are often regarded as detrimental byproducts of normal cellular activity, they also function as signaling molecules that regulate numerous physiological processes. Approximately one in 2,500 newborns is born with a congenital metabolic disorder, and the substantial heterogeneity among these conditions leads to wide variation in their clinical impact, prevalence, tissue involvement, and inheritance patterns. Comprehensive strategies using knowledge from fields such as molecular biology, biochemistry, computer modeling, and cell biology require a complete understanding of how reactive oxygen species (ROS) function in cells. This helps scientists decipher the role of ROS as a signal that affects many biological activities within the cell. This is most important as it is dangerous due to metabolic production, taking into account the fact that ROS can function as an important signal leading to cell growth, progression, evolution, and even cell death. The production of ROS resulting from a variety of intracellular and extracellular activities has attracted great attention as a novel signal molecule involved in processes such as cell motility, division, transformation, and mortality. The development of ROS in a typical physiological process is compensated by an antioxidant defense mechanism that protects cells from excessive amounts of dangerous ROS. Reactive oxygen species (ROS), which are free radicals containing oxygen, are important and have complex effects on the development and degradation of metabolic diseases. To improve outcomes, subsequent research efforts should prioritize the balance between the formation and removal of ROS, the determination of accurate ROS targets for various metabolic diseases, and the formulation of treatments that can modulate ROS signals.